Atazanavir
- Strength
- 300 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Camber Pharmaceuticals, Inc.
Atazanavir
Listed by Laurus Labs Limited
- Strength
- 150 mg/1
- Form
- Capsule
- Route
- Oral
- Class
- Protease Inhibitor
What it contains
- Atazanavir Sulfate 150 mg/1
FDA record
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Protease Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 42385-920 |
| FDA application | ANDA212579 |
| RxNorm concept | 402246 |
| Package sizes listed | 2 |
| Marketed since | April 2021 |
Other products containing Atazanavir
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Atazanavir
- Strength
- 200 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Camber Pharmaceuticals, Inc.
Atazanavir
- Strength
- 150 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Camber Pharmaceuticals, Inc.
Atazanavir
- Strength
- 300 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Laurus Labs Limited
Atazanavir
- Strength
- 200 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Laurus Labs Limited
Atazanavir Sulfate
- Strength
- 300 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Teva Pharmaceuticals USA, Inc.
Atazanavir Sulfate
Atazanavir
- Strength
- 100 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Aurobindo Pharma Limited
Atazanavir Sulfate
Atazanavir
- Strength
- 200 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Aurobindo Pharma Limited
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.